This inventor holds 2 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Northwestern University, The University of Chicago. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2,220 
2 out of 966 
Years Active: 2019-2020
Title: Innovations by Eugene Wyatt in Muscular Dystrophy Treatment
Introduction
Eugene Wyatt is an accomplished inventor based in Chicago, IL (US), known for his significant contributions to the field of genetic therapies. He holds 2 patents that focus on innovative methods for treating limb girdle muscular dystrophy type 2C. His work aims to improve the lives of patients suffering from this debilitating condition.
Latest Patents
Wyatt's latest patents include compositions and methods for correcting limb girdle muscular dystrophy type 2C using exon skipping. This invention is directed to one or more antisense polynucleotides and their use in pharmaceutical compositions. The strategy involves inducing exon skipping in the γ-sarcoglycan gene in patients suffering from Limb-Girdle Muscular Dystrophy-2C (LGM-D2C) or in patients at risk of such a disease. The invention also provides methods for preventing or treating muscular dystrophy, such as LGMD2C, by utilizing antisense polynucleotides. In some aspects, the invention offers an isolated antisense oligonucleotide that specifically hybridizes to an exon target region of a γ-sarcoglycan RNA. Additionally, it provides a method of inducing exon-skipping of a gamma sarcoglycan RNA by delivering an antisense oligonucleotide or a composition to a cell.
Career Highlights
Eugene Wyatt has had a notable career, working with prestigious institutions such as the University of Chicago and Northwestern University. His research has focused on advancing genetic therapies and improving treatment options for muscular dystrophy.
Collaborations
Wyatt has collaborated with esteemed colleagues, including Elizabeth McNally, to further his research and innovations in the field of muscular dystrophy.
Conclusion
Eugene Wyatt's contributions to the treatment of muscular dystrophy through innovative patenting and research highlight his dedication to improving patient outcomes. His work continues to pave the way for advancements in genetic therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile